Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

160mg once a week for 24 weeks

Patients received 200mg of rituximab intravenously at week 0 and week 2.

50-100mg, po, once per day (Qd) prescribed if needed and adjusted due to patient response

Warfarin should be used in patients with arterial thrombosis, and rivaroxaban should be replaced if the patient cannot reach the standard or cannot tolerate it

200mg, po, twice per day (Bid) prescribed，if tolerated by the patient， the dose should remain constant during the observation period

5-30mg, po, once per day(Qd) prescribed if needed and adjusted due to patient response